LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN • GB00BYMT0J19

65.845 USD
+1.94 (+3.03%)
Last: Feb 13, 2026, 02:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIVN. LIVN was compared to 186 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year LIVN was profitable.
  • LIVN had a positive operating cash flow in the past year.
  • In multiple years LIVN reported negative net income over the last 5 years.
  • Of the past 5 years LIVN 4 years had a positive operating cash flow.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.48%, LIVN is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
  • LIVN has a Return On Equity of -18.76%. This is in the better half of the industry: LIVN outperforms 61.83% of its industry peers.
  • With an excellent Return On Invested Capital value of 8.38%, LIVN belongs to the best of the industry, outperforming 86.02% of the companies in the same industry.
  • LIVN had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 8.83%.
  • The last Return On Invested Capital (8.38%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.48%
ROE -18.76%
ROIC 8.38%
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With an excellent Operating Margin value of 15.01%, LIVN belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • Looking at the Gross Margin, with a value of 68.50%, LIVN is in the better half of the industry, outperforming 75.27% of the companies in the same industry.
  • LIVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for LIVN remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • Compared to 1 year ago, LIVN has a worse debt to assets ratio.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.77, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
  • LIVN has a Altman-Z score (1.77) which is in line with its industry peers.
  • LIVN has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as LIVN would need 2.26 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.26, LIVN belongs to the top of the industry, outperforming 86.56% of the companies in the same industry.
  • LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of LIVN (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Altman-Z 1.77
ROIC/WACC0.97
WACC8.63%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.32. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN has a worse Current ratio (1.32) than 76.88% of its industry peers.
  • A Quick Ratio of 1.12 indicates that LIVN should not have too much problems paying its short term obligations.
  • LIVN has a worse Quick ratio (1.12) than 72.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
  • LIVN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.63%.
  • The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%

3.2 Future

  • Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.20% on average per year.
  • LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.10, which indicates a rather expensive current valuation of LIVN.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 88.17% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, LIVN is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 15.62, the valuation of LIVN can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 88.71% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of LIVN to the average of the S&P500 Index (27.69), we can say LIVN is valued slightly cheaper.
Industry RankSector Rank
PE 17.1
Fwd PE 15.62
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaply inside the industry as 84.95% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 91.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.73
EV/EBITDA 13.27
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.01
PEG (5Y)9.42
EPS Next 2Y11.85%
EPS Next 3Y10.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVANOVA PLC

NASDAQ:LIVN (2/13/2026, 2:56:07 PM)

65.845

+1.94 (+3.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners105.72%
Inst Owner Change-1.34%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.60B
Revenue(TTM)1.35B
Net Income(TTM)-217.00M
Analysts82.35
Price Target73.19 (11.15%)
Short Float %3.37%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)3.41%
PT rev (3m)12.77%
EPS NQ rev (1m)0.65%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 17.1
Fwd PE 15.62
P/S 2.67
P/FCF 18.73
P/OCF 14.33
P/B 3.11
P/tB 27.24
EV/EBITDA 13.27
EPS(TTM)3.85
EY5.85%
EPS(NY)4.22
Fwd EY6.4%
FCF(TTM)3.52
FCFY5.34%
OCF(TTM)4.6
OCFY6.98%
SpS24.7
BVpS21.2
TBVpS2.42
PEG (NY)1.01
PEG (5Y)9.42
Graham Number42.86
Profitability
Industry RankSector Rank
ROA -8.48%
ROE -18.76%
ROCE 11.71%
ROIC 8.38%
ROICexc 13.38%
ROICexgc 250.34%
OM 15.01%
PM (TTM) N/A
GM 68.5%
FCFM 14.23%
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.41%
ROICexc growth 3Y38.4%
ROICexc growth 5Y24.59%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Debt/EBITDA 1.41
Cap/Depr 132.77%
Cap/Sales 4.37%
Interest Coverage 250
Cash Conversion 101.63%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.12
Altman-Z 1.77
F-Score6
WACC8.63%
ROIC/WACC0.97
Cap/Depr(3y)78.92%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%
EBIT growth 1Y51.48%
EBIT growth 3Y51.06%
EBIT growth 5Y22.44%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2168.7%
FCF growth 3Y20.84%
FCF growth 5YN/A
OCF growth 1Y532.9%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.